Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.37% |
| 2 | Healthcare | 7.45% |
| 3 | Consumer Discretionary | 5.14% |
| 4 | Industrials | 5.1% |
| 5 | Financials | 4.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1301
Tecnoglass
TGLS
$2.09B
| $21.5M | 0.01% |
416,588
-306,372
| -42% | -$13.6M |
|
1302
CALL
Prudential Financial
PRU
$43B
| $21.5M | 0.01% |
243,900
-82,900
| -25% | -$6.94M |
|
1303
Ambev
ABEV
$48.4B
| $21.5M | 0.01% |
6,763,443
-7,833,705
| -54% | -$23M |
|
1304
CALL
Humana
HUM
$46.7B
| $21.5M | 0.01% |
48,100
-34,500
| -42% | -$17.4M |
|
1305
Sunrun
RUN
$2.3B
| $21.5M | 0.01% |
1,204,080
+101,532
| +9% | +$1.89M |
|
1306
CALL
First Solar
FSLR
$21.8B
| $21.5M | 0.01% |
113,000
+74,200
| +191% | +$14.7M |
|
|
MRSH
1307
CALL
Marsh
MRSH
$91.7B
| $21.4M | 0.01% |
114,000
+5,400
| +5% | +$958K |
|
1308
CALL
Progressive
PGR
$128B
| $21.4M | 0.01% |
161,800
+81,800
| +102% | +$11M |
|
1309
CALL
TC Energy
TRP
$70.5B
| $21.4M | 0.01% |
400,000
+148,800
| +59% | +$6.07M |
|
1310
PUT
Yum! Brands
YUM
$41.4B
| $21.3M | 0.01% |
153,400
-37,800
| -20% | -$5.12M |
|
1311
OmniAb
OABI
$286M
| $21.2M | 0.01% |
4,336,079
-1,133,499
| -21% | -$4.6M |
|
|
KDNY
1312
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $21.2M | 0.01% |
552,166
+303,712
| +122% | +$7.8M |
|
1313
CALL
Workday
WDAY
$39.4B
| $21.2M | 0.01% |
+93,900
| New | +$18.8M |
|
1314
CALL
United Microelectronic
UMC
$43.6B
| $21.2M | 0.01% |
2,682,500
+30,000
| +1% | +$247K |
|
1315
Highwoods Properties
HIW
$3.71B
| $21.2M | 0.01% |
885,167
+690,774
| +355% | +$15.3M |
|
1316
Leggett & Platt
LEG
$1.47B
| $21.1M | 0.01% |
713,405
+518,633
| +266% | +$16.3M |
|
1317
AbCellera Biologics
ABCL
$1.62B
| $21.1M | 0.01% |
3,267,618
+2,060,920
| +171% | +$14.1M |
|
1318
PUT
Aflac
AFL
$65.9B
| $21.1M | 0.01% |
302,400
-68,700
| -19% | -$4.6M |
|
1319
PUT
LyondellBasell Industries
LYB
$18.8B
| $21.1M | 0.01% |
229,800
-321,400
| -58% | -$29.4M |
|
1320
Myriad Genetics
MYGN
$502M
| $21.1M | 0.01% |
908,448
-476,943
| -34% | -$10.4M |
|
1321
Hormel Foods
HRL
$14.1B
| $21M | 0.01% |
522,899
+296,513
| +131% | +$11.9M |
|
1322
CALL
iShares MSCI Brazil ETF
EWZ
$9.13B
| $21M | 0.01% |
647,100
-1,422,800
| -69% | -$42.3M |
|
1323
PUT
Moderna
MRNA
$22.1B
| $21M | 0.01% |
172,500
+16,000
| +10% | +$2.13M |
|
1324
Baytex Energy
BTE
$2.86B
| $20.9M | 0.01% |
6,423,904
+4,964,216
| +340% | +$17.4M |
|
1325
Hanover Insurance
THG
$7.84B
| $20.9M | 0.01% |
185,277
+29,930
| +19% | +$3.55M |
|
Similar funds
Millennium Management's Q2 2023 Portfolio in Review
As of Q2 2023, Millennium Management held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Millennium Management deployed $14B of net new capital in Q2 2023, opening 869 new positions and adding to 2,214 existing holdings. Its largest new stake was ResMed: 632,015 shares worth $138M.
By sector, the portfolio is most concentrated in Technology at 8.4% of assets, up from 8.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Tesla, an estimated $491M trimmed.
- Millennium Management's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Millennium Management added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Millennium Management's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Millennium Management fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Millennium Management's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Millennium Management opened 869 new positions and closed 1,192 in Q2 2023.
- Millennium Management's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.